Truist Securities Maintains Buy on Eli Lilly, Raises Price Target to $525
Portfolio Pulse from richadhand@benzinga.com
Truist Securities analyst Gregg Gilbert has maintained a 'Buy' rating on Eli Lilly (NYSE:LLY) and raised the price target from $430 to $525.
July 20, 2023 | 2:28 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Eli Lilly's price target has been raised from $430 to $525 by Truist Securities, which maintains a 'Buy' rating on the stock.
The raised price target and maintained 'Buy' rating by Truist Securities indicates a positive outlook for Eli Lilly. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100